1. Volume 58, Issue 1, Pages 317-324 (July 2000)
A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome 
Kazuo Yoshioka, Yasuo Ohashi, Tadasu Sakai, Hiroshi Ito, Norishige Yoshikawa, Hajime Nakamura, Takakuni Tanizawa, Hiroyoshi Wada, Sunao Maki 
Kidney International 
Volume 58, Issue 1, Pages (July 2000)
DOI: /j x
Copyright © 2000 International Society of Nephrology Terms and Conditions

2. Figure 1
Trial profile. Two patients in each group were excluded from the analysis of the relapse rates because they did not achieve remission after allocation.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

3. Figure 2
Relapse rate (A) and cumulative remission rate (B) in mizoribine and placebo groups. Hazards ratio = 0.79; P = 0.13.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

4. Figure 3
Relapse rate (A) and cumulative remission rate (B) in the subgroup of patients aged 10 years or younger at the start of the trial. Hazards ratio = 0.56; P =
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

5. Figure 4
Distribution of the relapse risk index in the subgroup of patients by age at the start of the trial.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions